These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Any room left for new antiplatelet agents in acute coronary syndrome? Collet JP; Montalescot G Eur Heart J; 2013 Jun; 34(23):1699-701. PubMed ID: 23585493 [No Abstract] [Full Text] [Related]
32. Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions. White HD Am Heart J; 2011 Mar; 161(3):450-61. PubMed ID: 21392598 [TBL] [Abstract][Full Text] [Related]
33. Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. Tricoci P; Lokhnygina Y; Huang Z; Van de Werf F; Cornel JH; Chen E; Wallentin L; Held C; Aylward PE; Moliterno DJ; Jennings LK; White HD; Armstrong PW; Harrington RA; Strony J; Mahaffey KW Am Heart J; 2014 Dec; 168(6):869-77.e1. PubMed ID: 25458650 [TBL] [Abstract][Full Text] [Related]
34. Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis. Lièvre M; Cucherat M Fundam Clin Pharmacol; 2010 Jun; 24(3):385-91. PubMed ID: 19678849 [TBL] [Abstract][Full Text] [Related]
37. Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives. Turpie AG Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):963-76. PubMed ID: 25017622 [TBL] [Abstract][Full Text] [Related]
38. New antiplatelet agents: why they are needed. Franchini M; Mannucci PM Eur J Intern Med; 2009 Dec; 20(8):733-8. PubMed ID: 19892299 [TBL] [Abstract][Full Text] [Related]